We have revised our earnings estimates for 20/21/22E by +10.2%/-6.4%/-0.5% as we have become less optimistic on a recovery, given that the recent spike in COVID- 19 cases will deter local visitation and also push back plans to reopen borders for foreign tourists. We believe that the social distancing measures will remain in place at least until 6-12 months after a vaccine is publicly available. Although its casinos in Malaysia and Singapore have seen increases in local visitation post the reopening, we believe that this is still insufficient to compensate for the lack of foreign tourists, as foreign tourists contributed 25% and 75% of the total visitation in previous years.
Apart from lowering our visitation forecasts for both GENM and GENS, we have lowered the overall spending per visitation too, as we believe that the overall spending on gaming activities is likely to be lower due to the challenging global economic outlook. The extension of credit to VIP players might also be more stringent, as a weaker economic outlook might increase the risk of default, in our view. However, as GENS relies heavily on credit extension to attract VIP players, GENS might need to take on higher risk to speed up the recovery of its VIP segment. Nevertheless, the return of VIP is also dependent on the reopening of borders for general tourists.
There also lies the possibility that both Genting Berhad (GENT) and Genting Malaysia (GENM MK; RM2.03, Sell) might be dropped from the FBMKLCI Index by year end, due to the decline in their market capitalisations. Based on their current market caps, GENM is currently ranked at 35th place, while GENT is ranked at 34th place, and if they do fall below the 35th place, they will be replaced by other candidates, and it could be a de-rating catalyst for the stock.
Source: Affin Hwang Research - 18 Oct 2020
Chart | Stock Name | Last | Change | Volume |
---|
Created by kltrader | Jan 03, 2023
Created by kltrader | Sep 30, 2022